[Lethal enterovirus myocarditis associated with rituximab and chemotherapy for follicular lymphoma]

Med Clin (Barc). 2013 Nov 16;141(10):459-60. doi: 10.1016/j.medcli.2013.03.001. Epub 2013 Apr 23.
[Article in Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Murine-Derived / administration & dosage
  • Antibodies, Monoclonal, Murine-Derived / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Combined Modality Therapy
  • Enterovirus / isolation & purification*
  • Enterovirus Infections / etiology*
  • Fatal Outcome
  • Febrile Neutropenia / chemically induced
  • Febrile Neutropenia / complications
  • Humans
  • Immunocompromised Host
  • Immunoglobulins, Intravenous / therapeutic use
  • Lymphoma, Follicular / complications
  • Lymphoma, Follicular / drug therapy*
  • Lymphoma, Follicular / radiotherapy
  • Male
  • Multiple Organ Failure / etiology
  • Myocarditis / etiology*
  • Myocarditis / virology
  • Opportunistic Infections / etiology*
  • Opportunistic Infections / virology
  • Remission Induction
  • Rituximab
  • Shock, Cardiogenic / etiology

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Immunoglobulins, Intravenous
  • Rituximab